# DC1s-CTL Cellular Therapy for Renal Cell Carcinoma

> **NCT02787915** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Xuzhou Medical University** · enrollment: 50 (estimated)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **BIOLOGICAL:** DC1-CTL

## Key facts

- **NCT ID:** NCT02787915
- **Lead sponsor:** Xuzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-09
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2016-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02787915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02787915, "DC1s-CTL Cellular Therapy for Renal Cell Carcinoma". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02787915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*